Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.7.0 is displayed on the page, signaling a platform update. This change reflects an update to the site's version rather than any modification to the study data or displayed details.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a new revision label, v3.6.6, replacing the previous v3.6.5. This indicates a version update of the page content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a new build of the site; no visible content changes are indicated by this revision tag.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a new version of the study page. This change reflects an update to the page version rather than any new or modified content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small maintenance update. This update does not change the study details or visible content.SummaryDifference0.0%

- Check79 days agoChange DetectedAn updated informed consent form (Revision: v3.6.2) is now available as a PDF on the study page, replacing the older version. This update ensures current consent materials are accessible to participants.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.